316 related articles for article (PubMed ID: 37630472)
1. The Challenge of Overcoming Antibiotic Resistance in Carbapenem-Resistant Gram-Negative Bacteria: "Attack on Titan".
Mancuso G; De Gaetano S; Midiri A; Zummo S; Biondo C
Microorganisms; 2023 Jul; 11(8):. PubMed ID: 37630472
[TBL] [Abstract][Full Text] [Related]
2. Bacterial Epidemiology and Antimicrobial Resistance Profiles in Children Reported by the ISPED Program in China, 2016 to 2020.
Fu P; Xu H; Jing C; Deng J; Wang H; Hua C; Chen Y; Chen X; Zhang T; Zhang H; Chen Y; Yang J; Lin A; Wang S; Cao Q; Wang X; Deng H; Cao S; Hao J; Gao W; Huang Y; Yu H; Wang C
Microbiol Spectr; 2021 Dec; 9(3):e0028321. PubMed ID: 34730410
[TBL] [Abstract][Full Text] [Related]
3.
Guo Y; Han R; Jiang B; Ding L; Yang F; Zheng B; Yang Y; Wu S; Yin D; Zhu D; Hu F;
Microbiol Spectr; 2022 Aug; 10(4):e0185422. PubMed ID: 35862963
[TBL] [Abstract][Full Text] [Related]
4. Impact of COVID-19 pandemic on multidrug resistant gram positive and gram negative pathogens: A systematic review.
Abubakar U; Al-Anazi M; Alanazi Z; Rodríguez-Baño J
J Infect Public Health; 2023 Mar; 16(3):320-331. PubMed ID: 36657243
[TBL] [Abstract][Full Text] [Related]
5. Phenotypic and molecular characterization of Acinetobacter baumannii isolates causing lower respiratory infections among ICU patients.
Jain M; Sharma A; Sen MK; Rani V; Gaind R; Suri JC
Microb Pathog; 2019 Mar; 128():75-81. PubMed ID: 30562602
[TBL] [Abstract][Full Text] [Related]
6. ESCMID/EUCIC clinical practice guidelines on perioperative antibiotic prophylaxis in patients colonized by multidrug-resistant Gram-negative bacteria before surgery.
Righi E; Mutters NT; Guirao X; Del Toro MD; Eckmann C; Friedrich AW; Giannella M; Kluytmans J; Presterl E; Christaki E; Cross ELA; Visentin A; Sganga G; Tsioutis C; Tacconelli E
Clin Microbiol Infect; 2023 Apr; 29(4):463-479. PubMed ID: 36566836
[TBL] [Abstract][Full Text] [Related]
7. Global Threat of Carbapenem-Resistant Gram-Negative Bacteria.
Jean SS; Harnod D; Hsueh PR
Front Cell Infect Microbiol; 2022; 12():823684. PubMed ID: 35372099
[TBL] [Abstract][Full Text] [Related]
8. Impact of COVID-19 on Antimicrobial Consumption and Spread of Multidrug-Resistance in Bacterial Infections.
Jeon K; Jeong S; Lee N; Park MJ; Song W; Kim HS; Kim HS; Kim JS
Antibiotics (Basel); 2022 Apr; 11(4):. PubMed ID: 35453286
[TBL] [Abstract][Full Text] [Related]
9. The interface between COVID-19 and bacterial healthcare-associated infections.
O'Toole RF
Clin Microbiol Infect; 2021 Dec; 27(12):1772-1776. PubMed ID: 34111586
[TBL] [Abstract][Full Text] [Related]
10. Choice of therapeutic interventions and outcomes for the treatment of infections caused by multidrug-resistant gram-negative pathogens: a systematic review.
Nørgaard SM; Jensen CS; Aalestrup J; Vandenbroucke-Grauls CMJE; de Boer MGJ; Pedersen AB
Antimicrob Resist Infect Control; 2019; 8():170. PubMed ID: 31709047
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and
Cruz-López F; Martínez-Meléndez A; Morfin-Otero R; Rodriguez-Noriega E; Maldonado-Garza HJ; Garza-González E
Front Cell Infect Microbiol; 2022; 12():884365. PubMed ID: 35669117
[TBL] [Abstract][Full Text] [Related]
12. Epidemiology and outcomes associated with carbapenem-resistant Acinetobacter baumannii and carbapenem-resistant Pseudomonas aeruginosa: a retrospective cohort study.
Vivo A; Fitzpatrick MA; Suda KJ; Jones MM; Perencevich EN; Rubin MA; Ramanathan S; Wilson GM; Evans ME; Evans CT
BMC Infect Dis; 2022 May; 22(1):491. PubMed ID: 35610601
[TBL] [Abstract][Full Text] [Related]
13. Clinical and Economic Burden of Carbapenem-Resistant Infection or Colonization Caused by
Zhen X; Stålsby Lundborg C; Sun X; Gu S; Dong H
Antibiotics (Basel); 2020 Aug; 9(8):. PubMed ID: 32823707
[No Abstract] [Full Text] [Related]
14. Global Assessment of the Activity of Tigecycline against Multidrug-Resistant Gram-Negative Pathogens between 2004 and 2014 as Part of the Tigecycline Evaluation and Surveillance Trial.
Giammanco A; Calà C; Fasciana T; Dowzicky MJ
mSphere; 2017; 2(1):. PubMed ID: 28124025
[TBL] [Abstract][Full Text] [Related]
15. ESCMID-EUCIC clinical guidelines on decolonization of multidrug-resistant Gram-negative bacteria carriers.
Tacconelli E; Mazzaferri F; de Smet AM; Bragantini D; Eggimann P; Huttner BD; Kuijper EJ; Lucet JC; Mutters NT; Sanguinetti M; Schwaber MJ; Souli M; Torre-Cisneros J; Price JR; Rodríguez-Baño J
Clin Microbiol Infect; 2019 Jul; 25(7):807-817. PubMed ID: 30708122
[TBL] [Abstract][Full Text] [Related]
16. Treatment of multidrug-resistant Gram-negative skin and soft tissue infections.
Jabbour JF; Sharara SL; Kanj SS
Curr Opin Infect Dis; 2020 Apr; 33(2):146-154. PubMed ID: 32022742
[TBL] [Abstract][Full Text] [Related]
17. Update of clinical application in ceftazidime-avibactam for multidrug-resistant Gram-negative bacteria infections.
Zhen S; Wang H; Feng S
Infection; 2022 Dec; 50(6):1409-1423. PubMed ID: 35781869
[TBL] [Abstract][Full Text] [Related]
18. Multidrug-resistant Enterobacteriaceae, Pseudomonas aeruginosa, and vancomycin-resistant Enterococcus: Three major threats to hematopoietic stem cell transplant recipients.
Satlin MJ; Walsh TJ
Transpl Infect Dis; 2017 Dec; 19(6):. PubMed ID: 28815897
[TBL] [Abstract][Full Text] [Related]
19. [Impact of antimicrobial stewardship program on antimicrobial usage and detection rate of multidrug-resistant gram-negative bacteria].
Xu YL; Hu LM; Xie ZZ; Dong YW; Dong L
Zhonghua Er Ke Za Zhi; 2019 Jul; 57(7):553-558. PubMed ID: 31269557
[No Abstract] [Full Text] [Related]
20. Current situation of carbapenem-resistant Enterobacteriaceae and Acinetobacter in Japan and Southeast Asia.
Akeda Y
Microbiol Immunol; 2021 Jun; 65(6):229-237. PubMed ID: 33913535
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
